Indianapolis Clinical Site 121 — Indianapolis, Indiana

Indianapolis Clinical Site 121 is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Indianapolis Clinical Site 121 has participated in 2 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: EMD Serono, Ono Pharma USA Inc.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indianapolis Clinical Site 121?

Indianapolis Clinical Site 121 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indianapolis Clinical Site 121 conducted?

Indianapolis Clinical Site 121 has 2 clinical trials on record. Their work covers Multiple Sclerosis.

Is Indianapolis Clinical Site 121 accredited by Crixeo Health?

Indianapolis Clinical Site 121 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indianapolis Clinical Site 121?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.